Omoc-oc, Baby Boy .

HRN: 22-24-07  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/22/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/22/2022
11/29/2022
IVTT
45mg
Q24h
PSNB (MSAF)
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: